CUSIP 92686J106 · who reports it, how much, and how much it matters to them
39 of the 720 hedge fund managers we track reported shares of Viking Therapeutics, Inc. (Nasdaq: VKTX) on Form 13F for 30 June 2026. Between them they reported USD 416m. The largest position belongs to Two Sigma Investments, at USD 154m. The manager with the most riding on it is Blackbarn Capital Partners, where it is 2.0% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Two Sigma Investments35 funds on PPLI.com | USD 154m | 0.1% |
| 2 | D. E. Shaw & Co.15 funds on PPLI.com | USD 63m | 0.0% |
| 3 | Citadel Advisors32 funds on PPLI.com | USD 37m | 0.0% |
| 4 | Eversept Partners3 funds on PPLI.com | USD 24m | 1.2% |
| 5 | Blackbarn Capital Partners1 fund on PPLI.com | USD 23m | 2.0% |
| 6 | Millennium Management6 funds on PPLI.com | USD 19m | 0.0% |
| 7 | POINT72 Asset Management17 funds on PPLI.com | USD 18m | 0.0% |
| 8 | Exoduspoint Capital Management7 funds on PPLI.com | USD 14m | 0.1% |
| 9 | PFM Health Sciences3 funds on PPLI.com | USD 10m | 0.9% |
| 10 | Tudor Investment Corporation10 funds on PPLI.com | USD 7.7m | 0.0% |
| 11 | Artia Global Partners1 fund on PPLI.com | USD 7.1m | 1.3% |
| 12 | Balyasny Asset Management25 funds on PPLI.com | USD 4.5m | 0.0% |
| 13 | Persistent Asset Partners10 funds on PPLI.com | USD 4.4m | 1.3% |
| 14 | Bridgewater Associates45 funds on PPLI.com | USD 3.4m | 0.0% |
| 15 | Capital Fund Management S.A.12 funds on PPLI.com | USD 2.9m | 0.0% |
| 16 | Dafna Capital Management6 funds on PPLI.com | USD 2.3m | 0.4% |
| 17 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 2.1m | 0.0% |
| 18 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 2m | 0.1% |
| 19 | Exome Asset Management2 funds on PPLI.com | USD 1.9m | 1.2% |
| 20 | Engineers Gate Manager1 fund on PPLI.com | USD 1.8m | 0.0% |
| 21 | Marshall Wace LLP84 funds on PPLI.com | USD 1.7m | 0.0% |
| 22 | Squarepoint Ops7 funds on PPLI.com | USD 1.6m | 0.0% |
| 23 | Lighthouse Investment Partners190 funds on PPLI.com | USD 1.4m | 0.0% |
| 24 | Kintayl Capital2 funds on PPLI.com | USD 1.1m | 0.5% |
| 25 | Brevan Howard Capital Management39 funds on PPLI.com | USD 1.1m | 0.0% |
| 26 | Rock Springs Capital Management2 funds on PPLI.com | USD 995,000 | 0.0% |
| 27 | Graham Capital Management18 funds on PPLI.com | USD 863,000 | 0.0% |
| 28 | Oxford Asset Management LLP2 funds on PPLI.com | USD 633,000 | 0.3% |
| 29 | Fulcrum Asset Management LLP7 funds on PPLI.com | USD 606,000 | 0.1% |
| 30 | J. Goldman & Co.1 fund on PPLI.com | USD 589,000 | 0.0% |
| 31 | Water Island Capital1 fund on PPLI.com | USD 585,000 | 0.1% |
| 32 | Scientech Research2 funds on PPLI.com | USD 564,000 | 0.5% |
| 33 | Brandywine Managers47 funds on PPLI.com | USD 480,000 | 0.2% |
| 34 | Magnetar Financial93 funds on PPLI.com | USD 443,000 | 0.0% |
| 35 | Walleye Capital8 funds on PPLI.com | USD 441,000 | 0.0% |
| 36 | Arrowmark Colorado Holdings24 funds on PPLI.com | USD 385,000 | 0.0% |
| 37 | Lecap Asset Management1 fund on PPLI.com | USD 318,000 | 0.1% |
| 38 | Bayforest Capital1 fund on PPLI.com | USD 83,520 | 0.1% |
| 39 | The Quarry1 fund on PPLI.com | USD 1,092 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Blackbarn Capital Partners | USD 23m | 2.0% |
| 2 | Persistent Asset Partners | USD 4.4m | 1.3% |
| 3 | Artia Global Partners | USD 7.1m | 1.3% |
| 4 | Eversept Partners | USD 24m | 1.2% |
| 5 | Exome Asset Management | USD 1.9m | 1.2% |
| 6 | PFM Health Sciences | USD 10m | 0.9% |
| 7 | Scientech Research | USD 564,000 | 0.5% |
| 8 | Kintayl Capital | USD 1.1m | 0.5% |
| 9 | Dafna Capital Management | USD 2.3m | 0.4% |
| 10 | Oxford Asset Management LLP | USD 633,000 | 0.3% |
Viking Therapeutics, Inc. trades under the symbol VKTX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 92686J106.
39 of the 720 hedge fund managers PPLI.com tracks reported Viking Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Two Sigma Investments (USD 154m), D. E. Shaw & Co. (USD 63m), Citadel Advisors (USD 37m), Eversept Partners (USD 24m) and Blackbarn Capital Partners (USD 23m).
39 managers in our coverage reported it, and between them they run 799 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Blackbarn Capital Partners, where the position was 2.0% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Viking Therapeutics, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.